Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Receivables - Net (2020 - 2022)

Historic Receivables - Net for Tango Therapeutics (TNGX) over the last 3 years, with Q4 2022 value amounting to $2.0 million.

  • Tango Therapeutics' Receivables - Net changed 0.0% to $2.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was $2.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $2.0 million for FY2022, which is 0.0% changed from last year.
  • Per Tango Therapeutics' latest filing, its Receivables - Net stood at $2.0 million for Q4 2022, which was down 0.0% from $2.0 million recorded in Q3 2022.
  • Tango Therapeutics' 5-year Receivables - Net high stood at $8.0 million for Q3 2021, and its period low was $2.0 million during Q4 2020.
  • In the last 3 years, Tango Therapeutics' Receivables - Net had a median value of $2.0 million in 2020 and averaged $2.9 million.
  • Its Receivables - Net has fluctuated over the past 5 years, first changed by 0.0% in 2021, then plummeted by 7500.0% in 2022.
  • Tango Therapeutics' Receivables - Net (Quarter) stood at $2.0 million in 2020, then changed by 0.0% to $2.0 million in 2021, then changed by 0.0% to $2.0 million in 2022.
  • Its Receivables - Net was $2.0 million in Q4 2022, compared to $2.0 million in Q3 2022 and $2.0 million in Q2 2022.